https://openbell.ai/ 2026-09-24T17:12:30.271Z hourly 1.0 https://openbell.ai/support 2026-09-24T17:12:30.271Z monthly 0.7 https://openbell.ai/privacy 2026-09-24T17:12:30.271Z monthly 0.5 https://openbell.ai/terms 2026-09-24T17:12:30.271Z monthly 0.5 https://openbell.ai/feed.json 2026-09-24T17:12:30.271Z hourly 0.8 https://openbell.ai/news/VRT:1790269810288 2026-09-24T17:10:10.288Z daily 0.9 https://cdn.brandfetch.io/VRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vertiv Expands AI Data Center Cooling Push With New Acquisition Vertiv Holdings Co (NYSE: VRT) announced its agreement to acquire King Environmental Services Ltd., enhancing its fluid management and testing capabilities in Europe, the Middle East, and Africa. The acquisition aims to strengthen Vertiv's thermal management services as data centers increasingly adopt liquid cooling for AI and high-density computing workloads. Following the announcement, Vertiv's shares fell by 1.37% to $245.37. The deal is expected to close in Q4 2026, with no material impact on Vertiv's financial results anticipated. https://openbell.ai/news/VRT:1790269796562 2026-09-24T17:09:56.562Z daily 0.9 https://cdn.brandfetch.io/VRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vertiv Expands AI Data Center Cooling Push With New Acquisition Vertiv Holdings Co (NYSE: VRT) announced its agreement to acquire King Environmental Services Ltd., enhancing its fluid management and testing capabilities across Europe, the Middle East, and Africa. This acquisition aims to strengthen Vertiv's thermal management services as data centers increasingly adopt liquid cooling for AI and high-density computing workloads. Following the announcement, Vertiv's shares fell by 1.37% to $245.37. The deal is expected to close in the fourth quarter of 2026, with financial terms not disclosed. https://openbell.ai/news/BULL:1790269568002 2026-09-24T17:06:08.002Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/WebullNew-York--Usa---April-25--2025-Web.jpg?width=250&height=187 Why Is Webull Stock Falling on Thursday? Webull Corp (NASDAQ: BULL) shares fell 3.86% to $7.36 on Thursday, amidst broader market declines with the Nasdaq down 0.82% and S&P 500 down 0.54%. The stock has decreased 48.28% over the past year, leading to quicker profit-taking during market downturns. Additionally, President Anthony Michael Denier sold 53,846 shares on September 21, contributing to the stock's volatility as it trades below key short-term moving averages. https://openbell.ai/news/SPHL:1790269564261 2026-09-24T17:06:04.261Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session On Thursday, Springview Holdings (NASDAQ: SPHL) saw a significant increase of 23.1%, reaching $2.84, with a market cap of $5.2 million. Other notable gainers included J-Star Hldg (NASDAQ: YMAT) up 20.31% to $1.54, and Uxin (NASDAQ: UXIN) rising 16.5% to $1.27, with a market value of $228.5 million. Conversely, VisionSys AI (NASDAQ: VSA) experienced a sharp decline of 25.0% to $2.73, while Stitch Fix (NASDAQ: SFIX) fell 22.7% to $2.18, following the release of its Q4 earnings. https://openbell.ai/news/APUS:1790269564072 2026-09-24T17:06:04.072Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's Intraday Session On Thursday, Apimeds Pharmaceuticals (AMEX: APUS) saw a significant increase in its stock price, rising 162.4% to $6.01, with a market value of $3.4 million. Surrozen (NASDAQ: SRZN) also experienced a notable gain of 96.16%, reaching $31.7 and a market cap of $189.9 million. Conversely, Artelo Biosciences (NASDAQ: ARTL) faced a decline of 33.7%, dropping to $4.84, while Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE: CELGR) fell by 19.86% to $0.1. https://openbell.ai/news/SVRN:1790269563901 2026-09-24T17:06:03.901Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's Intraday Session On Thursday, SVRN stock surged by 42.8% to $46.49, bringing its market value to $61.0 million. Other notable gainers included Wetour Robotics, which rose 24.77% to $1.81, and Green Circle Decarbonize, up 24.1% to $0.63. In contrast, Professional Diversity saw a significant decline of 32.1% to $3.68, while NeoVolta dropped 27.17% to $2.31 following its Q4 earnings release. https://openbell.ai/news/ZSQR:1790269563646 2026-09-24T17:06:03.646Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's Intraday Session On Thursday, Z Squared (NASDAQ: ZSQR) saw a significant stock increase of 19.4%, reaching $3.54, with a market value of $156.8 million. Other notable gainers included Everpure (NYSE: P), which rose 16.26% to $127.48, and Quantum (NASDAQ: QMCO), which increased by 15.2% to $29.92. Conversely, Trio-Tech Intl (NASDAQ: TRT) experienced a substantial decline of 33.5% to $7.62 following its Q4 earnings report, while Hub Cyber Security (NASDAQ: HUBC) fell 26.8% to $2.35. https://openbell.ai/news/TRT:1790269464910 2026-09-24T17:04:24.910Z daily 0.9 https://cdn.brandfetch.io/TRT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trio-Tech shares are trading lower after the company reported a Q4 net loss and margin compression despite robust revenue growth and a more-than-doubled backlog. openbell Financial News https://openbell.ai/news/ECL:1790269458154 2026-09-24T17:04:18.154Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Konskie--Poland---January-16--2024-Ecola.jpg?width=250&height=187 This Water Stock Is Ready to Become an AI Leader, Bank of America Says Bank of America has identified Ecolab Inc. (NYSE: ECL) as a potential leader in the AI sector due to its recent acquisitions aimed at enhancing its water treatment business for semiconductor and AI server cooling applications. Ecolab's High-Tech water business is projected to grow from $1.5 billion to $4 billion by 2030, bolstered by the $1.8 billion acquisition of Ovivo and the $4.75 billion purchase of CoolIT Systems. The firm maintains a Buy rating with a price target of $342, suggesting a 24% upside from its current price of $274. https://openbell.ai/news/AIFU:1790269125074 2026-09-24T16:58:45.074Z daily 0.9 https://cdn.brandfetch.io/AIFU/w/400/h/400?c=1idopYfmtR7ZKg8QMud AIFU shares are trading higher. The company announced it completed a strategic share issuance to Expansion Group, which now holds a 63.4% ownership stake and about 99.4% of the company's voting power. openbell Financial News https://openbell.ai/news/FDX:1790268960939 2026-09-24T16:56:00.939Z daily 0.9 https://cdn.brandfetch.io/FDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of logistics, freight and delivery companies are trading lower as oil prices climb in response to elevated U.S.-Iran tensions after stalled bilateral talks, with Iranian President Pezeshkian saying, "we will not bow to U.S. pressure." Also, several business groups warned President Trump against a planned diesel export ban, suggesting it would be counterproductive and raise fuel prices. openbell Financial News https://openbell.ai/news/VLO:1790268823388 2026-09-24T16:53:43.388Z daily 0.9 https://cdn.brandfetch.io/VLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of oil and gas refining and marketing companies are trading higher after reports suggesting that multiple U.S. industry associations sent a letter to President Trump warning of serious market risks from a proposed 90-ban on diesel exports. openbell Financial News https://openbell.ai/news/EQPT:1790268729939 2026-09-24T16:52:09.939Z daily 0.9 https://cdn.brandfetch.io/EQPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching EquipmentShare.com; Blue Orca Capital Issues Report On Co, Stating It Holds A Short Position Blue Orca Capital has issued a report on EquipmentShare.com, stating that it holds a short position in the company. The report suggests concerns regarding EquipmentShare's financial performance and market position. The stock ticker for EquipmentShare is EQPT. https://openbell.ai/news/META:1790268520117 2026-09-24T16:48:40.117Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Meta Platforms shares are trading higher after multiple analysts maintained their Outperform, Overweight, or Strong Buy ratings on the stock and raised their respective price targets. openbell Financial News https://openbell.ai/news/XRPUSD:1790268435292 2026-09-24T16:47:15.292Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Crypto-Trader-Investor-Analyst-Broker-Us.jpg?width=250&height=187 XRP Is One Crypto This Analyst Won't Touch Again — Here's What He Prefers Instead Analyst Scott Melker has stated he will not invest in XRP again, criticizing the cryptocurrency for its lack of genuine utility and value creation. He emphasizes a shift in his investment strategy towards Bitcoin and other established digital assets like Ethereum and Solana, predicting that many smaller blockchain projects may fail. Melker remains bullish on Bitcoin, forecasting a potential price range of $220,000 to $250,000 in the next market cycle. https://openbell.ai/news/TSLA:1790268293304 2026-09-24T16:44:53.304Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Los-Angeles---Aug-22-Tesla-Model-Y-Drive.jpg?width=250&height=187 Tesla FSD Drove Over the Limit in 55% of Brussels Tests Ahead of EU Approval Vote Tesla Inc.'s Full Self-Driving (FSD) system exceeded legal speed limits on 55% of tested road segments in Brussels, averaging 44 km/h in areas marked for 30 km/h. The Belgian study raises concerns ahead of a potential EU vote on FSD approval, which could take place as early as October 6. While the Czech Republic provisionally approved FSD, Sweden and France have expressed opposition due to speeding issues, highlighting a divide among European regulators. https://openbell.ai/news/BE:1790268216472 2026-09-24T16:43:36.472Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Bloom-Energy-Logo-At-Their-Headquarters-.jpg?width=250&height=187 Why Is Bloom Energy Stock Falling Thursday? Bloom Energy Corp. (NYSE: BE) saw its stock fall over 6% to $257.70 on Thursday due to Oracle Corp.'s invocation of force majeure related to Project Jupiter, a significant data center project that relies on Bloom's fuel cells. The project faces potential delays, with a key natural gas pipeline now expected to be ready by February 1, 2027, which could impact Bloom's fuel-cell deployments and revenue timing. Despite this, Bloom has emphasized its diversified customer base and project flexibility, which it believes will support its growth trajectory. https://openbell.ai/news/NBIS:1790267635292 2026-09-24T16:33:55.292Z daily 0.9 https://cdn.brandfetch.io/NBIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nebius Group shares are trading higher after BNP Paribas upgraded the stock from Neutral to Outperform rating and raised its price target from $260 to $399. openbell Financial News https://openbell.ai/news/WELL:1790267434972 2026-09-24T16:30:34.972Z daily 0.9 https://cdn.brandfetch.io/WELL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Welltower shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight rating and announced a $260 price target. openbell Financial News https://openbell.ai/news/RCL:1790267275419 2026-09-24T16:27:55.419Z daily 0.9 https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Royal Caribbean Cruises shares are trading higher after JP Morgan maintained its Overweight rating on the stock and raised its price target from $345 to $394. openbell Financial News https://openbell.ai/news/UTHR:1790267129167 2026-09-24T16:25:29.167Z daily 0.9 https://cdn.brandfetch.io/UTHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud United Therapeutics shares are trading lower after Goldman Sachs initiated coverage on the stock with a Sell rating and announced a $321 price target. openbell Financial News https://openbell.ai/news/META:1790267105007 2026-09-24T16:25:05.007Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/In-this-photo-illustration--the-Meta-Mus.jpg?width=250&height=187 Here's How Meta's Muse Mania Is Spilling into Leveraged ETFs Meta Platforms, Inc. (NASDAQ: META) has seen its stock rise 3.38% to $769.22, nearing its 52-week high, following the launch of its Muse AI assistant on September 8, which has contributed to a 37% increase in the stock over the past month. The Muse launch has propelled Meta shares over 20% since its debut and has positively impacted leveraged ETFs, with the Leverage Shares 2X Long META Daily ETF (BATS: METG) gaining about 81% and the Direxion Daily META Bull 2X ETF (NASDAQ: METU) up approximately 82% in the same period. Analysts estimate that Muse could generate $10.8 billion in annual revenue by 2027 under aggressive adoption scenarios. https://openbell.ai/news/IONQ:1790267055971 2026-09-24T16:24:15.971Z daily 0.9 https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud IonQ Signs Contract To Install Superion 256 Quantum Computer At Florida International University, Expected Late 2027; Terms Not Disclosed openbell Financial News https://openbell.ai/news/ACAD:1790266976223 2026-09-24T16:22:56.223Z daily 0.9 https://cdn.brandfetch.io/ACAD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Acadia Pharma shares are trading lower after the company announced remlifanserin narrowly missed the primary endpoint in its Phase 2 RADIANT study for Alzheimer's disease psychosis. openbell Financial News https://openbell.ai/news/USO:1790266776994 2026-09-24T16:19:36.994Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud US And Iran Discuss Phased Deal To Reopen Strait Of Hormuz And End US Blockade, Sources Say US and Iran are reportedly in discussions regarding a phased deal aimed at reopening the Strait of Hormuz and ending the US blockade. This development could have significant implications for oil transportation and global markets, particularly affecting the USO stock, which is linked to oil prices. Further details on the negotiations and potential outcomes have not been disclosed. https://openbell.ai/news/USO:1790266537049 2026-09-24T16:15:37.049Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading higher as U.S.-Iran tensions remain elevated after stalled bilateral talks, with Iranian President Pezeshkian saying "we will not bow to U.S. pressure." Several business groups warned President Trump against a planned diesel export ban, suggesting it would be counterproductive and raise fuel prices. openbell Financial News https://openbell.ai/news/GOOGL:1790266306321 2026-09-24T16:11:46.321Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BNP Paribas And Google Cloud Announce Five-Year Agentic AI And Cloud Partnership; Terms Not Disclosed BNP Paribas has announced a five-year partnership with Google Cloud focused on agentic AI and cloud innovation. The terms of the partnership have not been disclosed. This collaboration aims to enhance BNP Paribas's technological capabilities and improve customer services. https://openbell.ai/news/VLO:1790266014953 2026-09-24T16:06:54.953Z daily 0.9 https://cdn.brandfetch.io/VLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Dozens Of U.S. Oil Refining And Business Groups Urge Trump To Reject Any Effort To Impose Ban On Diesel Exports Dozens of U.S. oil refining and business groups have sent a letter urging former President Trump to reject any efforts to impose a ban on diesel exports. The groups argue that such a ban would negatively impact the industry and the economy. This comes amid ongoing discussions about energy policies and their implications for the market. https://openbell.ai/news/LLY:1790265998532 2026-09-24T16:06:38.532Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Los-Angeles--California---July-7-2025-El.jpg?width=250&height=187 Lilly Wins FDA Nod For Weekly Insulin, Signs $3.25 Billion InnoCare Pact Eli Lilly and Co. received FDA approval for Onswik, a once-weekly insulin injection for type 2 diabetes, marking its fourth regulatory clearance globally. The approval was based on data from the QWINT Phase 3 clinical trials involving over 3,400 patients. Additionally, Lilly announced a strategic partnership with InnoCare Pharma, which could yield up to $3.25 billion in future milestone payments and royalties. Following these announcements, Lilly's stock rose by 3.42% to $1,190.32. https://openbell.ai/news/META:1790265688046 2026-09-24T16:01:28.046Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tigress Financial Maintains Strong Buy on Meta Platforms, Raises Price Target to $995 Tigress Financial analyst Ivan Feinseth has reiterated a Strong Buy rating on Meta Platforms (NASDAQ: META) and increased the price target from $945 to $995. This adjustment reflects positive sentiment towards the company's performance and growth potential. https://openbell.ai/news/GOOG:1790265582015 2026-09-24T15:59:42.015Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Launches Gemini 3.8 Live With Live Avatar For Enterprise AI Agents Google has launched Gemini 3.8, an advanced AI model featuring a live avatar designed for enterprise applications. This new model aims to enhance user interaction and engagement in AI-driven environments. The launch reflects Google's ongoing commitment to innovation in artificial intelligence, although specific financial impacts or stock price movements related to this release were not detailed. https://openbell.ai/news/SFIX:1790265429689 2026-09-24T15:57:09.689Z daily 0.9 https://cdn.brandfetch.io/SFIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Downgrades Stitch Fix to Market Perform William Blair analyst Dylan Carden has downgraded Stitch Fix (NASDAQ: SFIX) from an 'Outperform' rating to 'Market Perform'. This change reflects a reassessment of the company's performance and outlook in the market. https://openbell.ai/news/SRRK:1790265373627 2026-09-24T15:56:13.627Z daily 0.9 https://cdn.brandfetch.io/SRRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Scholar Rock Holding, Raises Price Target to $77 Truist Securities analyst Srikripa Devarakonda has maintained a 'Buy' rating on Scholar Rock Holding (NASDAQ: SRRK) and raised the price target from $76 to $77. https://openbell.ai/news/PPL:1790265329805 2026-09-24T15:55:29.805Z daily 0.9 https://cdn.brandfetch.io/PPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud PPL Electric Utilities Selected To Receive Up To $71.5M In Government Funding From U.S. Department Of Energy To Support Montour Grid Resilience, Advanced Reconductoring Project PPL Electric Utilities has been awarded up to $71.5 million in federal funding from the U.S. Department of Energy for the Montour Grid Resilience and Advanced Reconductoring Project. This initiative aims to modernize a 230-kilovolt transmission corridor and is part of the DOE's SPARK Program, which focuses on accelerating advanced transmission technology upgrades. https://openbell.ai/news/TLT:1790265302673 2026-09-24T15:55:02.673Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: The TLT ETF Tracking Long Duration Bonds Hits New Record Low The iShares 20+ Year Treasury Bond ETF (TLT) reached a record low of $79.71 as long-duration U.S. Treasury bonds experienced a sell-off. The 10-year Treasury yield rose to 5.11%, the highest since 2007, attributed to stronger-than-expected economic growth, with the U.S. Composite PMI at 58.4. Market analyst Ed Yardeni described the 5% yield as a 'vote of confidence' in the economy, while investor Peter Schiff warned it could lead to yields of 6% or higher, adding uncertainty ahead of the Federal Reserve's interest rate decision. https://openbell.ai/news/LGND:1790265245629 2026-09-24T15:54:05.629Z daily 0.9 https://cdn.brandfetch.io/LGND/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $358 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Ligand Pharmaceuticals (NASDAQ: LGND) and maintained a price target of $358. This endorsement suggests continued confidence in the company's performance and potential for growth. https://openbell.ai/news/TMO:1790265213561 2026-09-24T15:53:33.561Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpg?width=250&height=187 Thermo Fisher Stock Hits Record High: What's Happening? Thermo Fisher Scientific Inc. (NYSE: TMO) shares reached a record high of $681.55 on Thursday, surpassing its previous 52-week range, before settling around $668. This surge follows a strong second-quarter earnings report where the company reported adjusted earnings of $6.03 per share on nearly $12 billion in sales, a 10% year-over-year increase. Additionally, Thermo Fisher raised its full-year profit outlook to $24.93-$25.33 per share and sales guidance to $47.40 billion-$48.10 billion, anticipating a revenue growth of about 4%. https://openbell.ai/news/SEI:1790265126334 2026-09-24T15:52:06.334Z daily 0.9 https://cdn.brandfetch.io/SEI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Solaris Energy Infr, Raises Price Target to $100 Citigroup analyst Scott Gruber has reaffirmed a Buy rating on Solaris Energy Infrastructure (NYSE: SEI) and increased the price target from $84 to $100. This adjustment reflects positive expectations for the company's performance in the market. https://openbell.ai/news/AMC:1790265048604 2026-09-24T15:50:48.604Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Kiev--Ukraine---February-9--2021-In-This.jpg?width=250&height=187 Why Is AMC Stock Falling on Thursday? AMC Entertainment's stock fell 4.70% to $2.74 on Thursday following the announcement of a $3.97 billion debt refinancing package. The company priced $2 billion in first lien senior secured notes due 2031 at an 8.875% interest rate and an $850 million term loan facility at SOFR plus 4.50%. The refinancing aims to delay heavy debt obligations due in 2029 to 2031, but high interest rates may restrict the company's free cash flow for years. https://openbell.ai/news/P:1790264959057 2026-09-24T15:49:19.057Z daily 0.9 https://cdn.brandfetch.io/P/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Everpure, Raises Price Target to $160 Citigroup analyst Asiya Merchant has reiterated a Buy rating on Everpure (NYSE: P) and increased the price target from $130 to $160. This adjustment reflects a positive outlook for the company's performance in the market. https://openbell.ai/news/ARCT:1790264843204 2026-09-24T15:47:23.204Z daily 0.9 https://cdn.brandfetch.io/ARCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Upgrades Arcturus Therapeutics to Buy, Raises Price Target to $20 Citigroup analyst Yigal Nochomovitz has upgraded Arcturus Therapeutics (NASDAQ: ARCT) from Neutral to Buy. The price target for the stock has been raised significantly from $8 to $20. https://openbell.ai/news/SAIL:1790264768920 2026-09-24T15:46:08.920Z daily 0.9 https://cdn.brandfetch.io/SAIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on SailPoint, Raises Price Target to $27 Truist Securities analyst Junaid Siddiqui has maintained a Buy rating on SailPoint (NASDAQ: SAIL) and increased the price target from $23 to $27. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/TDY:1790264743276 2026-09-24T15:45:43.276Z daily 0.9 https://cdn.brandfetch.io/TDY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Teledyne Energy Systems Partners With NASA To Advance Next-Gen Space Power Technology Under Space Act Agreement Teledyne Energy Systems, a subsidiary of Teledyne Technologies (NYSE: TDY), has partnered with NASA under a Space Act Agreement to advance next-generation space power technology. The collaboration aims to mature Teledyne's Hydrogen Electrical Power System (HEPS) from Technology Readiness Level 5 to TRL 7, enhancing power systems for future lunar and deep-space missions. https://openbell.ai/news/BB:1790264668950 2026-09-24T15:44:28.950Z daily 0.9 https://cdn.brandfetch.io/BB/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported a fiscal second-quarter revenue of $163.3 million, a 26% increase year-over-year, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from a previous range of $594 million to $621 million, and adjusted EPS expectations to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, and adjusted EBITDA increased 81% to $47 million. Despite a 4.06% drop in stock price to $8.045, BlackBerry continues to invest in QNX and explore growth opportunities in Physical AI. https://openbell.ai/news/KYTX:1790264666219 2026-09-24T15:44:26.219Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Budget-Bill-Sparks-National-Controversy.jpg?width=250&height=187 Kyverna Therapeutics Therapy Delivers Sustained Relief in Rare Neurological Conditions Kyverna Therapeutics Inc. (NASDAQ: KYTX) reported positive 12-month results from trials of its miv-cel cell therapy for stiff-person syndrome and generalized myasthenia gravis (gMG). The KYSA-8 study showed a 49% median improvement in walking performance among 26 patients, with 95% of those achieving initial improvements maintaining benefits after one year. Additionally, all seven participants in the KYSA-6 trial for gMG reported meaningful improvements in daily activities, with 86% remaining off immunosuppressive therapies. Kyverna plans to complete its rolling Biologics License Application submission by Q4 2026. https://openbell.ai/news/BB:1790264619193 2026-09-24T15:43:39.193Z daily 0.9 https://cdn.brandfetch.io/BB/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported fiscal second-quarter 2027 revenue of $163.3 million, a 26% year-over-year increase, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from $594 million to $621 million, and adjusted EPS expectations to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, and adjusted EBITDA increased 81% to $47 million. Despite a 4.06% drop in share price to $8.045, BlackBerry's management expressed confidence in future growth driven by software-defined vehicles and partnerships in Physical AI. https://openbell.ai/news/PBR:1790264616801 2026-09-24T15:43:36.801Z daily 0.9 https://cdn.brandfetch.io/PBR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Petrobras CEO Speaking At RoG.e 2026 Says Company Close To Reaching 3M Barrels Per Day Of Oil Production Petrobras CEO announced at the RoG.e 2026 event that the company is nearing a milestone of 3 million barrels per day in oil production. This achievement reflects Petrobras's ongoing efforts to enhance its production capabilities. The announcement may have implications for the company's market position and stock performance, particularly for its ticker PBR. https://openbell.ai/news/BB:1790264574474 2026-09-24T15:42:54.474Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Blackberry.jpg?width=250&height=187 BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported a fiscal second-quarter revenue of $163.3 million, a 26% year-over-year increase, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from a previous forecast of $594 million to $621 million, and adjusted EPS guidance to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, contributing to an adjusted EBITDA of $47 million, an 81% increase. Despite a 4.06% drop in stock price to $8.045, BlackBerry remains optimistic about future growth opportunities in robotics and autonomous vehicles. https://openbell.ai/news/CTAS:1790264495241 2026-09-24T15:41:35.241Z daily 0.9 https://cdn.brandfetch.io/CTAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Cintas, Raises Price Target to $230 Truist Securities analyst Jasper Bibb has maintained a Buy rating on Cintas (NASDAQ: CTAS) and increased the price target from $225 to $230. This adjustment reflects a positive outlook on the company's performance. https://openbell.ai/news/SRZN:1790264490873 2026-09-24T15:41:30.873Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpg?width=250&height=187 Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy Surrozen Inc. (NASDAQ: SRZN) submitted an Investigational New Drug application to the FDA for its therapy SZN-8141, aimed at treating diabetic macular edema, leading to a 98.45% increase in its stock price to $32.07. The company plans to initiate a Phase 1b/2a clinical trial, DUET, with patient enrollment expected by late 2026 and initial results anticipated in the second half of 2027. As of June 30, Surrozen reported cash and cash equivalents of $102.0 million.